Monday, October 28, 2024 3:02:03 PM
Everyone can play along, L2 signals...GLTA HB
Market Maker Signals:
001 This happens when a market maker buys or sells just one share. It’s a test to see how the market reacts without
risking much money. For traders, a 1-share order might signal a bigger move is coming.
100 I need Shares
111 The “111” signal is neutral. It often means the market is consolidating, with no significant movement expected. Traders
might hold their positions and wait for a clearer signal.
121 This signal shows mixed feelings among market makers. It indicates uncertainty about the stock’s direction.
200 I need Shares badly but do not take the stock down
300 Take (or I am taking) the stock down at least 30% so I can load shares
400 Keep trading it sideways
500 Gap the stock. Gap can be up or down, depending on direction of 500 signal
505 I am short on shares
600 Apply resistance at the ASK to keep the price from increasing
666 This signal suggests a strong bearish sentiment. Traders see “666” and prepare for the stock price to drop.
700 Move the price up
777 Also recognized as a signal to move the price up
800 Prepare for an increase in trading volume
900 Allow the stock to float and trade freely
911 Pending News/Press Release On The Way
1000 Don't let it run. A “1000” signal points to high activity or strong interest in a stock. It suggests that market makers
are heavily involved, which can lead to increased volatility. Traders should prepare for sharp price movements.
2100 Let it run
Market Maker Signals:
001 This happens when a market maker buys or sells just one share. It’s a test to see how the market reacts without
risking much money. For traders, a 1-share order might signal a bigger move is coming.
100 I need Shares
111 The “111” signal is neutral. It often means the market is consolidating, with no significant movement expected. Traders
might hold their positions and wait for a clearer signal.
121 This signal shows mixed feelings among market makers. It indicates uncertainty about the stock’s direction.
200 I need Shares badly but do not take the stock down
300 Take (or I am taking) the stock down at least 30% so I can load shares
400 Keep trading it sideways
500 Gap the stock. Gap can be up or down, depending on direction of 500 signal
505 I am short on shares
600 Apply resistance at the ASK to keep the price from increasing
666 This signal suggests a strong bearish sentiment. Traders see “666” and prepare for the stock price to drop.
700 Move the price up
777 Also recognized as a signal to move the price up
800 Prepare for an increase in trading volume
900 Allow the stock to float and trade freely
911 Pending News/Press Release On The Way
1000 Don't let it run. A “1000” signal points to high activity or strong interest in a stock. It suggests that market makers
are heavily involved, which can lead to increased volatility. Traders should prepare for sharp price movements.
2100 Let it run
Bullish
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
